"Wegovy's Popularity Sparks Employer Insurance Coverage Reevaluation Amid Obesity Concerns"

The popularity of the obesity drug Wegovy is causing US employers to reconsider their insurance coverage for weight loss treatments. Previously, many employers covered weight-loss drugs, but the high cost and increased usage of Wegovy have prompted them to reassess reimbursement policies. Wegovy and similar drugs have been shown to help people lose around 15% of their body weight, but they come with a hefty price tag of over $1,000 per month. The rising demand for Wegovy has led to a significant increase in healthcare costs for employers, prompting them to introduce stricter eligibility requirements or even stop covering weight-loss drugs altogether.